Future of Genomic Medicine V conference set for March 1-2 in San Diego

January 18, 2012

SAN DIEGO (Jan. 18, 2012) - Scripps Translational Science Institute (STSI) will present its fifth annual educational conference exploring the latest achievements and challenges in the use of genomics to diagnose and treat disease and medical conditions on March 1-2, 2012, in San Diego.

The conference, The Future of Genomic Medicine V, will offer a dynamic, interactive forum where human geneticists, genomic scientists, physicians and health-care professionals of all disciplines can gain valuable insights from many of the nation's leading genomics experts.

The opening session will feature Noah and Alexis Beery, teenage twins who were successfully treated for a rare genetic disorder only when their entire genomes were sequenced after years of baffling symptoms and misdiagnosis. Their story illustrates how genomics is transforming the practice of medicine.

Other sessions will include an update on the Wellderly Study, which is examining the DNA of healthy elderly people to discover the genetic secrets to long life spans, as well as an overview of the confluence of genomics and medicine by Matthew Herper, a senior editor at Forbes magazine and author of The Medicine Show blog.

The program will include more than 30 specialized presentations interspersed with panel discussions and question-and-answer sessions. The March 1 schedule will focus on the emerging role of genetic testing in the diagnosis and treatment of diseases. Presentations on March 2 will cover a wide range of topics including cancer genomics, stem cells and the disruptive power of genomics in the field of medicine.

The conference is led by course director Eric J. Topol, M.D, chief academic officer of Scripps Health and director of STSI. His book, "The Creative Destruction of Medicine," will be released in hardback on Feb. 1. The program will take place at the Scripps Seaside Forum, located at 8610 Kennel Way, La Jolla, Calif., 92037.

Registration for the conference is $95 and is complimentary for all students, residents and fellows. Pre-registration will be accepted through Feb. 16, 2012, on a space-available basis. More information is available at www.scripps.org/conferenceservices or by calling Scripps Conference Services & CME at 858-652-5400.

Part of San Diego, Calif.-based Scripps Health, the Scripps Translational Science Institute (STSI) is a unique community collaboration that initiates research that moves basic science from the lab to the patient bedside. STSI is supported by the NIH flagship program, Clinical and Translational Science Award (CTSA). Collaborators in the STSI consortium include Scripps Health; The Scripps Research Institute; the Burnham Institute for Medical Research; Children's Hospital of Philadelphia; Genomics Institute of the Novartis Research Foundation; The J. Craig Venter Institute; Salk Institute for Biological Studies; San Diego State University; San Diego Supercomputer Center; and The Neurosciences Institute.


Founded in 1924 by philanthropist Ellen Browning Scripps, Scripps Health is a $2.45 billion nonprofit integrated health system based in San Diego, Calif. Scripps treats a half-million patients annually through the dedication of 2,600 affiliated physicians and 13,000 employees among its five acute-care hospital campuses, home health care services, and an ambulatory care network of physician offices and 23 outpatient centers and clinics.

Recognized as a leader in the prevention, diagnosis, and treatment of disease, Scripps is also at the forefront of clinical research, genomic medicine, wireless health care and graduate medical education. With three highly respected graduate medical education programs, Scripps is a longstanding member of the Association of American Medical Colleges. More information can be found at www.scripps.org.

Contact: Keith Darce
Phone: 858-678-7121
Cell: 858-336-9069

Scripps Health

Related Stem Cells Articles from Brightsurf:

SUTD researchers create heart cells from stem cells using 3D printing
SUTD researchers 3D printed a micro-scaled physical device to demonstrate a new level of control in the directed differentiation of stem cells, enhancing the production of cardiomyocytes.

More selective elimination of leukemia stem cells and blood stem cells
Hematopoietic stem cells from a healthy donor can help patients suffering from acute leukemia.

Computer simulations visualize how DNA is recognized to convert cells into stem cells
Researchers of the Hubrecht Institute (KNAW - The Netherlands) and the Max Planck Institute in Münster (Germany) have revealed how an essential protein helps to activate genomic DNA during the conversion of regular adult human cells into stem cells.

First events in stem cells becoming specialized cells needed for organ development
Cell biologists at the University of Toronto shed light on the very first step stem cells go through to turn into the specialized cells that make up organs.

Surprising research result: All immature cells can develop into stem cells
New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development.

The development of brain stem cells into new nerve cells and why this can lead to cancer
Stem cells are true Jacks-of-all-trades of our bodies, as they can turn into the many different cell types of all organs.

Healthy blood stem cells have as many DNA mutations as leukemic cells
Researchers from the Princess Máxima Center for Pediatric Oncology have shown that the number of mutations in healthy and leukemic blood stem cells does not differ.

New method grows brain cells from stem cells quickly and efficiently
Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells.

NUS researchers confine mature cells to turn them into stem cells
Recent research led by Professor G.V. Shivashankar of the Mechanobiology Institute at the National University of Singapore and the FIRC Institute of Molecular Oncology in Italy, has revealed that mature cells can be reprogrammed into re-deployable stem cells without direct genetic modification -- by confining them to a defined geometric space for an extended period of time.

Researchers develop a new method for turning skin cells into pluripotent stem cells
Researchers at the University of Helsinki, Finland, and Karolinska Institutet, Sweden, have for the first time succeeded in converting human skin cells into pluripotent stem cells by activating the cell's own genes.

Read More: Stem Cells News and Stem Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.